Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3941461 | Fertility and Sterility | 2009 | 4 Pages |
Abstract
Levonorgestrel (1.5 mg) is commonly used for emergency contraception to prevent an unwanted pregnancy after an unprotected intercourse. We found that postovulatory administration of 1.5 mg of levonorgestrel to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of estrogen receptors (ERα, ERβ), P receptors (PRB, PRA+B), androgen receptor (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Chun-Xia Meng, Li-Nan Cheng, Parameswaran Grace Luther Lalitkumar, Lin Zhang, Hui-Juan Zhang, Kristina Gemzell-Danielsson,